We suggested that ASAH1 may decrease the overall GBM survival and promote recurrence, which is inevitable, by enhancing the survival of irradiated GBMs via the upregulation of ASAH1, leading to decreasing levels of proapoptotic ceramide molecules and increasing levels of prosurvival S1P molecules (Figure 3) [96]. This evidence concerns the gene ASAH1 and glioblastoma.